IRLAB strengthens patent protection for Phase IIb/III drug candidate mesdopetam ...Middle East

STOCKHOLM, Dec. 8, 2020 /PRNewswire/ -- IRLAB (Nasdaq Stockholm: IRLAB A) announced today that the World Intellectual Property Organization, WIPO, has published a new patent application concerning drug candidate mesdopetam (IRL790). This composition of matter patent may extend the market...

Hence then, the article about irlab strengthens patent protection for phase iib iii drug candidate mesdopetam was published today ( Tuesday 08/12/2020 - 12:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IRLAB strengthens patent protection for Phase IIb/III drug candidate mesdopetam )

Also on site :

• Britney Spears Spends Time With Diane Warren and Molly Shannon After DUI
• 'You should resign': Mamata hits out at PM Modi's silence on Pakistan's threat to strike Kolkata
• IAEA: Continued military activity near Bushehr Plant could cause radiological accident